APA (7th ed.) Citation

MA, K., MH, L., A, M., I, P., M, A. S., C, G., . . . FGB, d. Q. (2022). Safety and immunogenicity of heterologous COVID-19 vaccine regimens to deal with product shortage: A randomised clinical trial in an elderly population. Public health in practice (Oxford, England), 4, 100313. https://doi.org/10.1016/j.puhip.2022.100313

Chicago Style (17th ed.) Citation

MA, Kundro, et al. "Safety and Immunogenicity of Heterologous COVID-19 Vaccine Regimens to Deal with Product Shortage: A Randomised Clinical Trial in an Elderly Population." Public Health in Practice (Oxford, England) 4 (2022): 100313. https://doi.org/10.1016/j.puhip.2022.100313.

MLA (9th ed.) Citation

MA, Kundro, et al. "Safety and Immunogenicity of Heterologous COVID-19 Vaccine Regimens to Deal with Product Shortage: A Randomised Clinical Trial in an Elderly Population." Public Health in Practice (Oxford, England), vol. 4, 2022, p. 100313, https://doi.org/10.1016/j.puhip.2022.100313.